Navigation Links
GPOs Fail to Provide Hospitals and Patients Health Care Savings
Date:10/6/2010

WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- Hospitals spend more each year on medical devices and equipment that are purchased through Group Purchasing Organizations (GPOs) than they would if purchased in the open-market according to a recent study commissioned by the Medical Device Manufacturers Association (MDMA).  The study empirically shows that GPOs fail to deliver on their primary justification for allowing them to receive kickbacks from suppliers, and that they do not in fact reduce costs.

(Logo: http://photos.prnewswire.com/prnh/20070227/DCTU110LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20070227/DCTU110LOGO)

"It is painfully clear that while hospitals and providers are trying to improve care and reduce costs for patients, the supplier-funded GPO model is costing the health care system billions," said MDMA President and CEO Mark Leahey.  "This study proves that GPOs not only fail to bend the cost curve for health care down, they are preventing hospitals and patients from getting the best products at the best prices.

"This study bolsters our argument that Congress must pass legislation that will restore the illegality of kickbacks between suppliers and GPOs," added Leahey.

The study, "Do Group Purchasing Organizations Achieve the Best Prices for Member Hospitals? An Empirical Analysis of Aftermarket Transactions," found that repealing the safe harbor statutes Congress passed in 1986 would reduce private U.S. health care expenditures by up to $25 billion each year.  This would also reduce federal health care spending by approximately $11.5 billion annually.  Aftermarket transactions show that GPO member hospitals and health care providers would save up to $37.5 billion based on 2010's most recent data.

Other key findings of the study include:

  • Hospitals saved an average of 10 percent between 2001 through 2010 when they purchased medical devices aftermarket, when GPOs supposedly negotiated the best price;
  • In 2010, the savings for hospitals was up to 18 percent for aftermarket purchases.

This groundbreaking study follows a 2009 report that showed hospitals could save approximately $8 billion each year if the safe harbor provisions were removed for GPOs.

GPOs were established to save hospitals money on the purchase of supplies and equipment. For decades hospitals funded these GPOs. However, with the creation of a safe harbor by Congress in 1986, the GPOs became reliant on suppliers for funding.

The Congressional exemption allows GPOs to legally collect fees from suppliers to whom they award contracts. Contractual arrangements that have evolved between GPOs and their hospital customers frequently exclude competitive medical technologies that could help patients and allow hospitals to reduce costs.

The full study is available at www.medicaldevices.org.

MDMA is a national trade association based in Washington, DC, representing hundreds of innovative, entrepreneurial companies in the medical device industry. MDMA seeks to improve the quality of patient care by encouraging the development of new medical technologies and fostering the availability of innovative products in the marketplace.


'/>"/>
SOURCE Medical Device Manufacturers Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
2. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
3. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
4. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
5. Raptor Pharmaceuticals Provides Update of Product Programs
6. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
7. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
8. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
9. Most Women With HIV and Their Health Care Providers Have Not Discussed How HIV Might Affect Them Differently Than Men
10. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
11. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
Breaking Medicine Technology:
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):